Piperazine

Piperazine

SCHEMBL28129606

C1CNCCN1.[SeH2].c1ccccc1

nearest known ligand 0.60

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ESR1

The experimentally established mechanism targets of Piperazine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HIF1A Q16665 1/20 0.60
MAPT P10636 1/20 0.60
PDE4A P27815 1/20 0.60
KDR P35968 1/20 0.60
CXCR4 P61073 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
KDM4E B2RXH2 1/20 0.38
GAA P10253 1/20 0.38
CYP2C9 P11712 1/20 0.38
HTR2C P28335 1/20 0.37
SIGMAR1 Q99720 3/20 0.36
OPRM1 P35372 1/20 0.36
HTR3E A5X5Y0 1/20 0.36
HTR3B O95264 1/20 0.36
ADRB1 P08588 1/20 0.36
HTR3A P46098 1/20 0.36
HTR3D Q70Z44 1/20 0.36
HTR3C Q8WXA8 1/20 0.36
SLC18A3 Q16572 1/20 0.36
ALDH1A1 P00352 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Piperazine SCHEMBL27368847 0.95 HIF1A (0.67) HIF1AMAPTPDE4AKDRCXCR4
Piperazine SCHEMBL27291765 0.95 HIF1A (0.67) HIF1AMAPTPDE4AKDRCXCR4
Piperazine SCHEMBL27963342 0.90 HIF1A (0.60) HIF1AMAPTPDE4AKDRCXCR4
Benzene SCHEMBL27478517 0.89
Piperazine SCHEMBL27452555 0.86 HIF1A (0.55) HIF1AMAPTPDE4AKDRCXCR4
Piperazine SCHEMBL27906538 0.84
Piperazine SCHEMBL28116810 0.82 HIF1A (0.50) HIF1AMAPTPDE4AKDRCXCR4
Benzene SCHEMBL28714782 0.82 CXCR4 (0.75) HIF1AMAPTPDE4AKDRCXCR4
SCHEMBL576335 0.78 HIF1A (1.00) HIF1AMAPTPDE4AKDRCXCR4
SCHEMBL2373879 0.78 HIF1A (1.00) HIF1AMAPTPDE4AKDRCXCR4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110036028-A anti-IL 1-RAP antibodies 塞勒兰特治疗公司 2019-07-19 CN disclosed
CN-108780094-A The diagnostic method of use condition active antibodies 生物蛋白有限公司 2018-11-09 CN disclosed
CN-106459960-A Conditionally active biological proteins 生物蛋白有限公司 2017-02-22 CN disclosed